Comparing the Effectiveness of Antidepressants and Cognitive Behavioural Therapy in Preventing Postnatal Depression:

Nadia Shaik1

  • 1Medicine, Salford Royal NHS Foundation Trust, Manchester, GBR.

Cureus
|October 27, 2025
PubMed

Insights

Selective serotonin reuptake inhibitors (SSRIs) offered faster anxiety symptom relief for postnatal depression (PND) compared to cognitive behavioural therapy (CBT). However, CBT showed a quicker decline in symptoms after 12 weeks, indicating tailored treatment approaches are beneficial.

Area of Science:

  • Psychiatry
  • Perinatal Mental Health
  • Evidence-Based Medicine

Background:

  • Postnatal depression (PND) is a common condition impacting maternal and infant well-being.
  • Anxiety frequently co-occurs with PND, complicating treatment and outcomes.

Purpose of the Study:

  • To systematically compare the efficacy of antidepressant medications (SSRIs) and cognitive behavioural therapy (CBT) for treating PND.
  • To evaluate short-term and long-term symptom reduction in PND patients receiving either SSRIs or CBT.

Main Methods:

  • A systematic review and meta-analysis of randomized controlled trials (RCTs) published between 1997 and 2019.
  • Searched PubMed and Medline databases following PRISMA guidelines.
  • Included four RCTs (N=421) from the UK, USA, and Australia.

Main Results:

  • SSRIs showed significantly greater anxiety symptom reduction at 4 and 18 weeks compared to CBT.
  • CBT demonstrated a faster decline in anxiety symptoms after 12 weeks.
  • Both SSRIs and CBT achieved significant overall clinical improvements; combination therapy offered no additional benefit.

Conclusions:

  • SSRIs may offer superior short-term and sustained anxiety relief in PND.
  • CBT might provide better long-term symptom management for PND.
  • Treatment choice should be individualized based on symptom severity, side effects, breastfeeding status, and patient preference.

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
797
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.4K
Cognitive Therapy01:25

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
877
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.4K
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
768
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
849